![]() ![]() 1 Currently, 6 general-use GBCAs are available and approved for a variety of MRI indications, including brain, body, and breast imaging in adults and children. With more than 450 million doses administered worldwide over the past 4 decades, GBCAs have a proven record of both safety and efficacy. Gadolinium-based contrast agents (GBCAs) are frequently administered to improve the sensitivity and/or specificity of diagnostic magnetic resonance imaging (MRI).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |